Rein Therapeutics reported earnings of per RNTX share on Nov 13, 2026, falling short of analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 0.10 |
| Last Year's EPS | -$ 0.46 |
| EPS YoY Change |
Out of the last 18 earnings reporting periods, Rein Therapeutics beat analysts’ expectations 8 times and fell short of expectations 9 time(s). Rein Therapeutics reported earnings per share of in the last report surpassing an estimated EPS of -$ 0.10 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.10 | -$ 1.89 | - | |
| Aug 14, 2026 | -$ 0.17 | -$ 0.10 | -$ 0.27 | |
| May 15, 2026 | -$ 0.49 | -$ 0.19 | -$ 0.45 | |
| Mar 26, 2026 | -$ 1.09 | -$ 1.09 | -$ 0.86 | |
| Nov 14, 2025 | -$ 0.24 | -$ 0.21 | -$ 0.86 | |
| Aug 14, 2025 | -$ 0.22 | -$ 0.28 | -$ 1.54 | |
| Apr 7, 2025 | -$ 0.14 | -$ 0.26 | -$ 0.40 | |
| Dec 31, 2024 | -$ 0.46 | -$ 1.89 | -$ 0.39 | |
| Nov 14, 2024 | -$ 0.25 | -$ 0.27 | -$ 0.39 | |
| Aug 14, 2024 | -$ 0.25 | -$ 0.45 | - | - |
| May 15, 2024 | -$ 0.14 | -$ 0.86 | - | - |
| Mar 31, 2024 | -$ 0.14 | -$ 0.86 | - | - |
| Dec 31, 2023 | -$ 0.16 | -$ 1.54 | - | - |
| Sep 30, 2023 | -$ 0.20 | -$ 0.40 | - | - |
| Aug 11, 2023 | -$ 0.40 | -$ 0.39 | - | - |
| Jun 30, 2023 | -$ 0.40 | -$ 0.39 | - | - |
| May 8, 2023 | -$ 0.60 | - | - | |
| Mar 20, 2023 | -$ 1.30 | - | - |
Rein Therapeutics’s stock was trading at $ 0.56 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | | $ 0.56 | ||
| Aug 14, 2026 | -$ 0.10 | $ 0.7875 | $ 0.8413 | |
| May 15, 2026 | -$ 0.19 | $ 1.13 | $ 1.04 | |
| Mar 26, 2026 | -$ 1.09 | $ 1.30 | $ 1.25 | |
| Nov 14, 2025 | -$ 0.21 | $ 1.35 | $ 1.22 | |
| Aug 14, 2025 | -$ 0.28 | $ 1.20 | $ 1.19 | |
| Apr 7, 2025 | -$ 0.26 | $ 1.70 | $ 1.39 | |
| Dec 31, 2024 | -$ 1.89 | $ 2.32 | $ 2.25 |
Rein Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Rein Therapeutics beat analysts’ expectations during the last earnings period by
